JD Enright

TMGcore Chief Executive Officer

As the chief executive officer of TMGcore, JD Enright oversees global operations, and is responsible for both regulatory affairs and core product development, among other areas. JD Enright works with the global head of commercial manufacturing and other C-suite executives to develop and commercialize products and services which encorporate thier patented two-phase liquid immersion computing technology.

In the role, he draws on an extensive career in technolgy leadership. With Lonza, Mr. Enright served as Sr. Director of its Global Strategic Growth Investments Group and held the position of General Manager and its emerging technologies division during which time he oversaw its Viral Cell and Gene Therapy growth program in Houston. Through the initiative, he directed the creation of the world's largest R&D and Commercial viral cell therapy campus.

The center, which spans 19 acres, uses state of the art technology and features commercial and clinical manufacturing techniques. In managing the project, JD Enright was responsible for obtaining investment capital alongside overseeing its development.

Plano, TX, US


Work Experience

Jan 2018 - Present

CEO
TMGcore

Mar 2016 - Jun 2018

Lonza, Lonza

Aug 2013 - Mar 2016

Vacaville Site Lead- Genentech CCP-2 RTS C&Q Project

Genentech


Education

Jan 2011 - Jun 2012

Cornell

Program Development

Jan 2005 - Jun 2007

Bachelor of Science (BS)
The Wharton School
Finance

Villanova University

LEAN - Six Sigma

Powered by CakeResumePowered by CakeResume